Vaniqa
NDC Package 67402-040-45
Package Information
Vaniqa is a medication used to slow down the growth of unwanted hair on the face and under the chin in women. Marketed by Skinmedica Pharmaceuticals, Inc., this product is identified by NDC 67402-040 and is authorized under FDA application NDA021145.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67402 - Skinmedica Pharmaceuticals, Inc.
- 67402-040 - Vaniqa
- 67402-040-45 - 1 TUBE in 1 PACKAGE / 45 g in 1 TUBE
- 67402-040 - Vaniqa
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (67402-040). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67402-040-45 identifies a specific commercial package of 1 tube in 1 package / 45 g in 1 tube of Vaniqa, labeled by Skinmedica Pharmaceuticals, Inc.. This product is billed per "GM" gram and contains an estimated amount of 45 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Skinmedica Pharmaceuticals, Inc. on August 01, 2000. The current certification is valid through August 01, 2014.
What are the primary indications for this medication?
This medication is used to slow down the growth of unwanted hair on the face and under the chin in women. It should not be used for hair on other parts of the body. It blocks a certain natural substance (an enzyme) that is needed for hair growth in the skin. This effect slows hair growth and may also make the hair finer and lighter. It does not remove hair or cause the hair to fall out. This drug is not for use in children younger than 12 years.
How is this Skinmedica Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67402004045. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 45 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.